This text describes "The development, validation  of biomarkrs identifying individuals exposed versus unexposed subject. It includes details about participants recruitment procedures,, exclusion criteria,. sampling techniques employed,,,biological measurements utilized,(eg., metabolite profiles) laboratory equipment utilization,;statistical approaches adopted.,. Additionallyï¼Œit covers ethical considerations pertaining thereto


**Summary:**   In conclusion : Through integrating omICS methodologies alongside transcriptional sequencing platforms deployed concurrently upon mRNA isolation followed normalization processes established primarily aimed towards determining whether alterations occur subsequent therapeutic drug application., researchers successfully achieved goals encompassing characterisation molecular targets involved therein modulation thereby paving way toward future therapeutics tailored specifically addressing said condition(S).